Mechanism of Action
- Anti-thrombin mediated inhibition of factor Xa
Half-Life
Metabolism
- Renal excretion
- ~20% removed by HD
Dosing – Adult
Dosing – Pediatric
- Please refer to pediatric section for information on use in children
Monitoring
- Consider Antifactor Xa level 4 hrs after 3rd dose for weight >120 kg or <60 kg
*Lower doses may be considered for patients at risk for bleeding and stroke patients
**Favor twice daily dosing for patients with cancer or high risk of bleeding or thrombosis. For patients who are obese use actual body weight to calculate dose.
***Obese patients may require a decreased starting dose if dosing is based upon their actual body weight. Consider starting these patients at 12 IU/kg/hr based on actual body weight and titrating the dose based upon UFH levels.
